Michael Paulista – CEO
Michael is the founder of Biopharm and Symbiosis. He created Biopharm in 1986 in the growing biotech ecosystem of Heidelberg. Since, he has succeeded to create a Growth Factor Platform Technology around the proprietary growth factor GDF-5. With Biopharm, he has developed several partnerships and licenses with big companies as Johnson and Johnson, Medtronic or Merck. He has also led Biopharm and Symbiosis to the GMP/GLP approval and to build biosafety level 2 laboratories (to work with viruses). With the success of analytical services offered by Biopharm since 2004, Michael decided to split R&D and analytical services in two entities, leading to the creation of Symbiosis.